Cargando…

Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria

BACKGROUND: A substantial number of persons living with HIV (PLWH) in Nigeria do not experience durable viral suppression on first-line antiretroviral therapy (ART). Understanding risk factors for first-line treatment failure informs patient monitoring practices and distribution of limited resources...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ndembi, Nicaise, Murtala-Ibrahim, Fati, Tola, Monday, Jumare, Jibreel, Aliyu, Ahmad, Alabi, Peter, Mensah, Charles, Abimiku, Alash’le, Quiñones-Mateu, Miguel E., Crowell, Trevor A., Rhee, Soo-Yon, Shafer, Robert W., Gupta, Ravindra, Blattner, William, Charurat, Manhattan E., Dakum, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640637/ https://www.ncbi.nlm.nih.gov/pubmed/33143751 http://dx.doi.org/10.1186/s12981-020-00317-9

Ejemplares similares

Performance and trend for quality of service in a large HIV/AIDS treatment program in Nigeria
por: Aliyu, Ahmad, et al.
Publicado: (2019)

Demography and the dual epidemics of tuberculosis and HIV: Analysis of cross-sectional data from Sub-Saharan Africa
por: Aliyu, Gambo, et al.
Publicado: (2018)

Correlates and determinants of Early Infant Diagnosis outcomes in North-Central Nigeria
por: Dakum, Patrick, et al.
Publicado: (2019)

Characterisation of HIV-1 Molecular Epidemiology in Nigeria: Origin, Diversity, Demography and Geographic Spread
por: Nazziwa, Jamirah, et al.
Publicado: (2020)

Missed opportunities for early infant diagnosis of HIV in rural North-Central Nigeria: A cascade analysis from the INSPIRE MoMent study
por: Anaba, Udochisom C., et al.
Publicado: (2019)

Prevalence and characteristics of metabolic syndrome and its components among adults living with and without HIV in Nigeria: a single-center study
por: Jumare, Jibreel, et al.
Publicado: (2023)

Predictors of loss to follow-up in art experienced patients in Nigeria: a 13 year review (2004–2017)
por: Aliyu, Ahmad, et al.
Publicado: (2019)

A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria
por: James, Onyemata E., et al.
Publicado: (2017)

Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria
por: Ekong, Ernest, et al.
Publicado: (2020)

Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria
por: Aliyu, Gambo, et al.
Publicado: (2014)

Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria
por: Anude, Chuka J, et al.
Publicado: (2013)

Dynamics of the infant gut microbiota in the first 18 months of life: the impact of maternal HIV infection and breastfeeding
por: Grant-Beurmann, Silvia, et al.
Publicado: (2022)

Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria
por: Royal, Walter, et al.
Publicado: (2016)

Prevalence of Non-Tuberculous Mycobacterial Infections among Tuberculosis Suspects in Nigeria
por: Aliyu, Gambo, et al.
Publicado: (2013)

Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria
por: El Bouzidi, Kate, et al.
Publicado: (2021)

Prevalence and risk factors for obesity among elderly patients living with HIV/AIDS in a low-resource setting
por: Dakum, Patrick, et al.
Publicado: (2021)

Diagnostic system strengthening for drug resistant tuberculosis in Nigeria: impact and challenges
por: Aliyu, Gambo, et al.
Publicado: (2017)

High prevalence of integrase mutation L74I in West African HIV-1 subtypes prior to integrase inhibitor treatment
por: El Bouzidi, Kate, et al.
Publicado: (2020)

Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria
por: Bada, Florence O., et al.
Publicado: (2020)

Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria
por: Bada, Florence O., et al.
Publicado: (2021)

Optimising Mycobacterium tuberculosis detection in resource limited settings
por: Alfred, Nwofor, et al.
Publicado: (2014)

Immunity in Nigerian women and the effects of pregnancy and infectious disease exposure on fetal immunity
por: Cairo, Cristiana, et al.
Publicado: (2006)

Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors
por: Charurat, Man, et al.
Publicado: (2010)

Social barriers in accessing care by clients who returned to HIV care after transient loss to follow-up
por: Adelekan, Babatunde, et al.
Publicado: (2019)

Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria
por: Aliyu, Gambo, et al.
Publicado: (2013)

A3 Molecular epidemiology of HIV-1 in Nigeria
por: Nazziwa, J, et al.
Publicado: (2019)

Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics
por: Volz, Erik M., et al.
Publicado: (2017)

Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells
por: DeMarino, Catherine, et al.
Publicado: (2018)

Publisher Correction: Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells
por: DeMarino, Catherine, et al.
Publicado: (2018)

Cost of three models of care for drug-resistant tuberculosis patients in Nigeria
por: Bada, Florence O., et al.
Publicado: (2019)

Prevalence of hypertension among patients aged 50 and older living with human immunodeficiency virus
por: Dakum, Patrick, et al.
Publicado: (2019)

Doing No Harm? Adverse Events in a Nation-Wide Cohort of Patients with Multidrug-Resistant Tuberculosis in Nigeria
por: Avong, Yohanna Kamabi, et al.
Publicado: (2015)

Performance of SARS COV-2 IgG Anti-N as an Independent Marker of Exposure to SARS COV-2 in an Unvaccinated West African Population
por: Abdullahi, Adam, et al.
Publicado: (2023)

Effect of community antiretroviral therapy on treatment outcomes among stable antiretroviral therapy patients in Nigeria: A quasi experimental study
por: Dakum, Patrick, et al.
Publicado: (2021)

Correlates of self-reported and biomarker based adherence to daily oral HIV pre-exposure prophylaxis among a cohort of predominantly men who have sex with men in Nigeria
por: Adeyemi, Olusegun A., et al.
Publicado: (2023)

Comprehensive Reference Ranges for Hematology and Clinical Chemistry Laboratory Parameters Derived from Normal Nigerian Adults
por: Miri-Dashe, Timzing, et al.
Publicado: (2014)

Evaluation of accuracy and performance of self-reported HIV and antiretroviral therapy status in the Nigeria AIDS Indicator and Impact Survey (2018)
por: Jahun, Ibrahim, et al.
Publicado: (2022)

Assuring the quality of diagnostic testing: The future is now
por: Nkengsong, John, et al.
Publicado: (2016)

Implementation of and Early Outcomes From Anal Cancer Screening at a Community-Engaged Health Care Facility Providing Care to Nigerian Men Who Have Sex With Men
por: Nowak, Rebecca G., et al.
Publicado: (2019)

In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix
por: Datir, Rawlings, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5oqj03u4qk96khjel4p0l25oj5